A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota

2017 ◽  
Vol 8 (12) ◽  
pp. 4644-4656 ◽  
Author(s):  
Le Zhao ◽  
Qi Zhang ◽  
Weini Ma ◽  
Feng Tian ◽  
Hongyi Shen ◽  
...  

Administration of a combination of quercetin and resveratrol may have beneficial effects on ameliorating HFD-induced obesity and reducing HFD-induced gut microbiota dysbiosis.

2019 ◽  
Vol 10 (10) ◽  
pp. 6517-6532 ◽  
Author(s):  
Hang Xu ◽  
Chunfang Zhao ◽  
Yutian Li ◽  
Ruiyu Liu ◽  
Mingzhang Ao ◽  
...  

Pyracantha fortuneana fruit extract (PFE) exhibits beneficial effects on IBF in association with the modulation of glycolipid digestion and gut microbiota in HFD-fed obese rats.


2019 ◽  
Vol 71 ◽  
pp. 72-88 ◽  
Author(s):  
Zahra Safari ◽  
Magali Monnoye ◽  
Peter M. Abuja ◽  
Mahendra Mariadassou ◽  
Karl Kashofer ◽  
...  

2020 ◽  
Vol 11 (6) ◽  
pp. 5525-5537 ◽  
Author(s):  
Dianzhi Hou ◽  
Qingyu Zhao ◽  
Laraib Yousaf ◽  
Borui Chen ◽  
Yong Xue ◽  
...  

This study aimed to investigate the beneficial effects of whole and decorticated mung beans on the regulation of serum glucose and lipid disorders in HFD/STZ-induced prediabetic mice, and to further explore their gut microbiota modulatory effects.


Gut ◽  
2020 ◽  
Vol 69 (12) ◽  
pp. 2259.1-2259 ◽  
Author(s):  
Tianyu Liu ◽  
Bangmao Wang ◽  
Hailong Cao

2018 ◽  
Vol 9 (10) ◽  
pp. 5371-5380 ◽  
Author(s):  
Shan Li ◽  
Junhui Li ◽  
Guizhu Mao ◽  
Tiantian Wu ◽  
Yaqin Hu ◽  
...  

A high-fat diet (HFD) has been a major contributor to increasing morbidity caused by metabolic syndromes.


2021 ◽  
Vol 12 ◽  
Author(s):  
Ying Shi ◽  
Ruixue Feng ◽  
Jieqi Mao ◽  
Shuangping Liu ◽  
Zhilei Zhou ◽  
...  

Hyperlipidemia is a chronic disorder that is difficult to cure and usually treated with long-term lipid-reducing drugs. Recent trends have led to the use of diet therapies or food-derived strategies in the treatment of such long-term diseases. The Chinese rice wine (huangjiu) contains a wide range of bioactive peptides that are produced during the multi-species fermentation process. To clarify the regulation effects of lipid metabolism and gut microbiota by huangjiu bioactive peptides, three huangjiu peptides were isolated, purified and characterized by hyper-filtration, macroporous resin, gel filtration separation and structural identification. Meanwhile, a mouse model of high-fat diet-induced hyperlipidemia was established to study the effects of huangjiu peptides on serum biomarker, hepatic metabolism and gut microbiota dysbiosis. Experimental results showed that huangjiu peptides T1 and T2 (HpT1, HpT2) treatment alleviated the increase in serum total cholesterol, triglyceride, low-density lipoprotein cholesterol levels and aberrant hepatic lipid accumulation in the high-fat diet-induced hyperlipidemia mice. Furthermore, HpT2 and HpT1 restored the α-diversity and structure of gut microbial community after hyperlipidemia-induced microbiota disturbance compared with simvastatin and HpT3. The administration of HpT2 and HpT1 regulated the microbiota-mediated gut ecology through alterations of characteristic taxa including Lactobacillus, Ileibacterium, Faecalibaculum and Alloprevotella by linear discriminant analysis effect size analysis. Collectively, our results offer new insights into the abilities of food-derived peptides on alleviation of high-fat diet-induced hyperlipidemia, hepatic steatosis and gut dysbiosis in mice.


Sign in / Sign up

Export Citation Format

Share Document